By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Horizon Pharma plc 

Connaught House, 1st Floor
1 Burlington Road
Dublin 4      Ireland
Phone: +353-1-72-2100 Fax:


Company News
Horizon Pharma (HZNP) Announces Pricing Of Public Offering Of Ordinary Shares 4/17/2015 11:01:22 AM
Horizon Pharma (HZNP) Announces The U.S. Patent And Trademark Office Issuance Of An Additional Notice Of Allowance With Claims Covering PENNSAID2% 4/17/2015 10:53:15 AM
Horizon Pharma (HZNP) Announces Proposed Public Offering Of Ordinary Shares 4/14/2015 12:48:45 PM
Horizon Pharma (HZNP) Receives FDA Fast Track Designation For ACTIMMUNE In The Treatment Of Friedreich's Ataxia 4/10/2015 11:51:55 AM
Horizon Pharma (HZNP) Names Geoffrey M. Curtis Group Vice President, Corporate Communications 4/9/2015 10:03:36 AM
Horizon Pharma (HZNP) Acquires Hyperion Therapeutics (HPTX) and Its Revenue-Boosting Pipeline for $1.1B 3/30/2015 7:40:34 AM
Horizon Pharma (HZNP) To Acquire Hyperion Therapeutics (HPTX) For $46.00 Per Share Or $1.1 Billion In Cash 3/30/2015 6:44:24 AM
Horizon Pharma plc.  (HZNP) And The Chicago Innovation Awards To Ring The Nasdaq Stock Market Closing Bell 3/23/2015 1:04:40 PM
Horizon Pharma plc.  (HZNP) Closes Offering Of $400 Million Of 2.50% Exchangeable Senior Notes, Including Exercise In Full Of Option To Purchase Additional Notes 3/17/2015 1:01:09 PM
Horizon Pharma plc.  (HZNP) Prices Offering Of $350 Million Of 2.50% Exchangeable Senior Notes 3/9/2015 11:54:54 AM